The miRNA content of circulating exosomes in DLBCL patients and in vitro influence of DLBCL-derived exosomes on miRNA expression of healthy B-cells from peripheral blood [0.03%]
DLBCL患者循环小胶质细胞的miRNA组成及体外DLBCL衍生的小胶质细胞对外周血健康B细胞miRNA表达的影响
Vildan Caner,Gokhan Ozan Cetin,Sibel Hacioglu et al.
Vildan Caner et al.
Background: Due to the heterogeneous nature of Diffuse Large B-cell Lymphoma (DLBCL), the mechanisms underlying tumor development and progression have not yet been fully elucidated. ...
Genetic and epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinoma [0.03%]
基于免疫细胞浸润的遗传和表观遗传景观鉴定肺癌腺癌中的免疫预后因素
Seema Khadirnaikar,Annesha Chatterjee,Sudhanshu Kumar Shukla
Seema Khadirnaikar
Background: Leukocyte infiltration plays an critical role in outcome of various diseases including Lung adenocarcinoma (LUAD). Objectives: ...
Identifying GNG4 might play an important role in colorectal cancer TMB [0.03%]
识别GNG4可能在结直肠癌TMB中起重要作用
Hongcan Zhao,Danli Sheng,Ze Qian et al.
Hongcan Zhao et al.
Background: Colorectal carcinoma (CRC) is one of the most leading cause of cancer death all over the world. The tumor immune microenvironment is illustrated to be necessary for the progress of CRC. And the accumulating ev...
Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt [0.03%]
埃及肿瘤坏死因子相关凋亡诱导配体受体1（TRAIL-R1）基因多态性与B细胞非霍奇金淋巴瘤易感性的关系研究
Mervat Khorshied,Nohair Soliman,Ola Khorshid et al.
Mervat Khorshied et al.
Background: Dysregulated apoptosis is a hallmark of cancer development and progression. TRAIL and its receptors (R1 and R2) are key players in the extrinsic apoptotic pathway. Genetic alteration or blockade of TRAIL-R1 ma...
Integrative genome wide analysis of protein tyrosine phosphatases identifies CDC25C as prognostic and predictive marker for chemoresistance in breast cancer [0.03%]
整合泛基因组分析蛋白酪氨酸磷酸酶发现CDC25C是乳腺癌化疗抗性预后和预测标志物
Rachel Topno,Nazia Nazam,Pallawi Kumari et al.
Rachel Topno et al.
Background: The breast cancer subtype deficient in estrogen receptor and human epidermal growth factor receptor-2 (ER-/HER2-) displays enhanced aggressiveness, metastasis and disease relapse due to chemoresistance. ER-/HE...
LncRNA LINC00858 enhances cervical cancer cell growth through miR-3064-5p/ VMA21 axis [0.03%]
长链非编码RNA LINC00858通过miR-3064-5p/VMA21轴促进宫颈癌细胞增殖
Min Wei,Youguo Chen,Wensheng Du
Min Wei
Background: Cervical cancer (CC) is the most common form of gynecological malignancy. Long intergenic non-protein coding RNA 858 (LINC00858) has been identified to participate in multiple cancers. However, the role and me...
Notice of retraction [0.03%]
撤稿通知
Retraction of Publication
Cancer biomarkers : section A of Disease markers. 2021;31(4):419. DOI:10.3233/CBM-210952 2021
Lymphocyte C-reactive protein ratio: A new biomarker to predict early complications after gastrointestinal oncologic surgery [0.03%]
淋巴细胞C反应蛋白比率：胃肠道肿瘤手术后早期并发症的新预测生物标志物
Murat Yildirim,Bulent Koca
Murat Yildirim
Background: Lymphocyte-to-C-reactive protein ratio (LCR) has been used as a post-surgical prognostic biomarker in patients with gastric and colorectal cancer. However, its relationship with early postoperative complicatio...
Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer [0.03%]
肿瘤相关抗原与自身抗体谱联合检测在肺癌早期诊断中的临床价值分析
Renren Ouyang,Shiji Wu,Bo Zhang et al.
Renren Ouyang et al.
Background: This study aimed to investigate the efficiency of combining tumor-associated antigens (TAAs) and autoantibodies in the diagnosis of lung cancer. ...
Dynamic changes in practical inflammation and immunity markers in cancer patients receiving immune-enhancing nutritional supplementation during concurrent chemoradiotherapy [0.03%]
免疫营养补充剂联合放化疗过程中改善癌症患者实用炎症和免疫标志物的动态变化研究
Nontiya Homkham,Pooriwat Muangwong,Veeradej Pisprasert et al.
Nontiya Homkham et al.
Background: Immune-enhancing nutrition (IMN) strengthens the systematic inflammatory response and the immune system. Neutrophil to lymphocyte ratio (NLR) and absolute lymphocyte count (ALC) are affected during cancer ther...